- Home
- REFI vs SOPH Comparison
REFI vs SOPH Comparison
Compare REFI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- SOPH
- Stock Information
- Founded
- REFI 2021
- SOPH 2011
- Country
- REFI United States
- SOPH Switzerland
- Employees
- REFI N/A
- SOPH N/A
- Industry
- REFI Real Estate Investment Trusts
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REFI Real Estate
- SOPH Health Care
- Exchange
- REFI Nasdaq
- SOPH Nasdaq
- Market Cap
- REFI 306.1M
- SOPH 247.0M
- IPO Year
- REFI 2021
- SOPH 2021
- Fundamental
- Price
- REFI $15.39
- SOPH $3.40
- Analyst Decision
- REFI Buy
- SOPH Strong Buy
- Analyst Count
- REFI 2
- SOPH 3
- Target Price
- REFI $20.00
- SOPH $7.00
- AVG Volume (30 Days)
- REFI 73.0K
- SOPH 21.9K
- Earning Date
- REFI 11-07-2024
- SOPH 11-05-2024
- Dividend Yield
- REFI 12.22%
- SOPH N/A
- EPS Growth
- REFI N/A
- SOPH N/A
- EPS
- REFI 1.97
- SOPH N/A
- Revenue
- REFI $55,186,946.00
- SOPH $64,938,000.00
- Revenue This Year
- REFI N/A
- SOPH $7.70
- Revenue Next Year
- REFI $4.51
- SOPH $20.61
- P/E Ratio
- REFI $7.81
- SOPH N/A
- Revenue Growth
- REFI 5.63
- SOPH 20.14
- 52 Week Low
- REFI $13.86
- SOPH $2.70
- 52 Week High
- REFI $17.65
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- REFI 42.89
- SOPH 44.10
- Support Level
- REFI $15.37
- SOPH $3.22
- Resistance Level
- REFI $15.85
- SOPH $3.66
- Average True Range (ATR)
- REFI 0.13
- SOPH 0.20
- MACD
- REFI -0.00
- SOPH 0.01
- Stochastic Oscillator
- REFI 22.22
- SOPH 58.60
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.